In the past decade, microvesicles (MVs) and CD36 have increasingly been considered as possible biomarkers for obesity, the metabolic syndrome (MetSy), type 2 diabetes mellitus (T2DM). This evidence concerns the gene CD36 and obesity due to melanocortin 4 receptor deficiency.